Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB for ESWL
NCT04213924Unknown
- Sponsor
- Atatürk University
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of bupivacaine hydrochloride 0.75% injection and Lidocaine Hydrochloride Injection, without epinephrine in pain (2 arms), sponsored by Atatürk University. Primary endpoint: Opioid Consumption. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injectionLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04213924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04213924.